上海药物所新型拓扑异构酶抑制剂研究取得新进展- 生命科学研究动态 ...
上海药物所新型拓扑异构酶抑制剂研究取得新进展- 生命科学研究动态 ...: 桔霉素三聚体Tricitrinol B结构拓扑异构酶II(Topo II)抑制剂是一类重要的抗肿瘤药物。目前临床上使用的Topo II抑制剂存在着毒副作用大、易产生耐药性的缺点,而新型Topo II ... 上海药物所新型拓扑异构酶抑制剂研究取得新进展,生命科学论坛.
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.